Steele Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Steele Capital Management's AMGN Position: Q3 2024 in Review
Steele Capital Management sold out of Amgen (AMGN) in Q3 2024, closing a stake of 1,288 shares — an estimated $403K sold.
Steele Capital Management first reported a position in AMGN in Q4 2023 and held it in 3 quarters. The position peaked at $403K in Q2 2024. 2,824 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.
- Steele Capital Management reported no remaining Amgen position as of Q3 2024 after selling out during the quarter.
- Steele Capital Management sold 1,288 Amgen shares in Q3 2024, an estimated $403K.
- Steele Capital Management first reported a position in Amgen in Q4 2023 and held it in 3 quarters.
- Steele Capital Management's Amgen position peaked at $403K in Q2 2024.
- 2,824 funds tracked by Wall St. Rank held Amgen as of Q3 2024.
Based on Steele Capital Management's 13F filing for Q3 2024, filed 8 Nov 2024.